INO
Inovio Pharmaceuticals Inc
Price:  
6.81 
USD
Volume:  
212,576.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 7.4%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 7.60%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 6.65%.

Range Selected
Cost of equity 6.50% - 8.70% 7.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.4% - 8.4% 7.4%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.09 0.09
Cost of debt 6.30% 7.00%
After-tax WACC 6.4% 8.4%
Selected WACC 7.4%